ATE305799T1 - Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung, mit einem antibiotikum und einem expektorans - Google Patents

Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung, mit einem antibiotikum und einem expektorans

Info

Publication number
ATE305799T1
ATE305799T1 AT01948942T AT01948942T ATE305799T1 AT E305799 T1 ATE305799 T1 AT E305799T1 AT 01948942 T AT01948942 T AT 01948942T AT 01948942 T AT01948942 T AT 01948942T AT E305799 T1 ATE305799 T1 AT E305799T1
Authority
AT
Austria
Prior art keywords
antibiotic
compositions
expectorant
production
pharmaceutical compositions
Prior art date
Application number
AT01948942T
Other languages
English (en)
Inventor
A Abdul Rahman Shoa
Original Assignee
New Pharma Res Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Pharma Res Sweden Ab filed Critical New Pharma Res Sweden Ab
Application granted granted Critical
Publication of ATE305799T1 publication Critical patent/ATE305799T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01948942T 2000-01-31 2001-01-29 Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung, mit einem antibiotikum und einem expektorans ATE305799T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00101857A EP1121940A1 (de) 2000-01-31 2000-01-31 Pharmazeutische zusammensetzungen mit einem antibiotikum und bromhexine, und verfahren zur ihrer herstellung
PCT/EP2001/000927 WO2001056610A1 (en) 2000-01-31 2001-01-29 Stabilised pharmaceutical compositions and process for their preparation comprising an antibiotic and an expectorant

Publications (1)

Publication Number Publication Date
ATE305799T1 true ATE305799T1 (de) 2005-10-15

Family

ID=8167724

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01948942T ATE305799T1 (de) 2000-01-31 2001-01-29 Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung, mit einem antibiotikum und einem expektorans

Country Status (8)

Country Link
EP (2) EP1121940A1 (de)
CN (1) CN1250291C (de)
AT (1) ATE305799T1 (de)
AU (1) AU2001228513A1 (de)
DE (1) DE60113807T2 (de)
DK (1) DK1251874T3 (de)
ES (1) ES2250427T3 (de)
WO (1) WO2001056610A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004023930A1 (de) * 2004-05-12 2005-12-08 Boehringer Ingelheim Vetmedica Gmbh Schnell lösliches Granulat von Bromhexin/Bromhexinhydrochlorid, Verfahren zu dessen Herstellung und dessen Verwendung
CN100409835C (zh) * 2007-04-06 2008-08-13 张嵩 含有溴己新盐的组合物及大容量注射剂和注射剂制备方法
KR101943812B1 (ko) * 2010-07-12 2019-01-31 사노피-아벤티스 도이칠란트 게엠베하 브롬헥신을 포함하는 수성 조성물
CN104224765B (zh) * 2014-09-03 2016-08-24 河北仁合益康药业有限公司 一种愈酚溴新口服溶液组合物
CN105534889B (zh) * 2016-01-07 2018-11-02 河北仁合益康药业有限公司 一种吸入用盐酸溴己新溶液组合物及其制备方法
CN105496952B (zh) * 2016-01-07 2018-11-02 河北仁合益康药业有限公司 一种吸入用盐酸溴己新溶液组合物及其制备方法
RU2637645C1 (ru) * 2016-12-27 2017-12-05 федеральное государственное бюджетное образовательное учреждение высшего образования "Хакасский государственный университет им. Н.Ф. Катанова" (ФГБОУ ВО ХГУ им. Н.Ф. Катанова) Способ непрямой эндолимфатической терапии при бронхопневмонии у собак
CN111714477B (zh) * 2020-07-23 2021-06-15 山东迅达康兽药有限公司 祛痰组合物及其口服液制备方法
CN120210105B (zh) * 2025-05-27 2025-09-12 江西省人民医院 一种从诱导痰中提取细胞外囊泡的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234683A (en) * 1985-06-18 1993-08-10 Emory University Method of stimulating the immune system
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
US5202241A (en) * 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
US5302486A (en) * 1992-04-17 1994-04-12 Xerox Corporation Encapsulated toner process utilizing phase separation
EP0587135A1 (de) * 1992-09-11 1994-03-16 Boehringer Ingelheim Vetmedica Gmbh Erhöhte chemotherapeutische Zusammensetzung gegen mikrobielle Infektionen bei Fischen, enthaltend ein Benzylaminderivat und eine antimicrobielle Substanz
GB2323532B (en) * 1997-03-27 2001-08-22 Bakulesh Mafatlal Khamar Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients

Also Published As

Publication number Publication date
AU2001228513A1 (en) 2001-08-14
EP1121940A1 (de) 2001-08-08
ES2250427T3 (es) 2006-04-16
DE60113807T2 (de) 2006-07-13
CN1396834A (zh) 2003-02-12
DE60113807D1 (de) 2006-02-16
EP1251874A1 (de) 2002-10-30
WO2001056610A1 (en) 2001-08-09
EP1251874B1 (de) 2005-10-05
CN1250291C (zh) 2006-04-12
DK1251874T3 (da) 2006-02-27

Similar Documents

Publication Publication Date Title
IL158589A (en) Carboxylic acid substituted oxazole derivatives, process for their manufacture, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment and prophylaxis of diseases which are modulated by ppar-alpha and -gamma activators
ATE326264T1 (de) Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung
SE9301489D0 (sv) Veterinary composition
NO20060113L (no) Pyrrolo(3,4-c)pyrazolderivater aktive som kinase inhibitorer
CY1108514T1 (el) Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
HUP0104867A3 (en) Heterocyclic compounds useful in the treatment of inflammatory diseases, process for their preparation, pharmaceutical compositions comprising thereof and their use
WO2005000232A3 (en) Six membered amino-amide derivatives as angiogenesis inhibitors
DE69932939D1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
WO2005014572A8 (en) Pyrimidylpyrrole derivatives active as kinase inhibitors
DE60230066D1 (de) Pharmazeutische zusammensetzung zur behandlung von psoriasis und anderen hautkrankheiten
DK1450771T3 (da) Farmaceutiske præparater til behandling af hudlæsioner og slimhinder og fremgangsmåder og kits til anvendelse heraf
JPS62223115A (ja) 歯周病治療剤
DE60301570D1 (de) 1,2,3-substituierte indolizinderivate, fgf inhibitoren, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
DE60113807D1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung, mit einem antibiotikum und einem expektorans
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
ATE340561T1 (de) Verwendung von antiseptika zur herstellung von arzneimitteln zur prophylaxe und behandlung von entzündungen im korperinneren des menschen
DE60130270D1 (de) Verfahren zur herstellung einer pharmazeutischen zubereitung mit 5-aminosalicylsäure zur verwendung bei der behandlung von colitis ulcerosa und morbus crohn
WO2003024996A3 (de) Antibakterielle makrozyklen
SE0001916D0 (sv) Novel formulation
WO2001089282A3 (en) 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
WO2004085436A3 (en) Pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
JO2335B1 (en) Fixed pharmaceutical formulations and method of preparation including antibiotic and repellent

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1251874

Country of ref document: EP